Applying interventions designed to reduce and manage the symptoms of substance use disorders.
Treatment
Evento SONEPSYN / ISSUP Chile: Chemsex
Este lunes 11 de julio, a las 20:00 hrs. se realizará la reunión académica del Grupo de Trabajo de Adicciones de Sonepsyn, junto a ISSUP-Chile.
Respiratory events associated with concomitant opioid and sedative use among Medicare beneficiaries with chronic obstructive pulmonary disease
Abstract Background Opioids and sedatives are commonly prescribed in chronic obstructive pulmonary disease (COPD) patients for symptoms of dyspnoea, pain, insomnia, depression and anxiety. Older adults are advised to avoid these medications...
Adaptation of the Universal Treatment Curriculum to Philippine Context and Online Environment
BACKGROUND: The Universal Treatment Curriculum (UTC) is offered to the academic community to integrate substance use-specific knowledge, skills, and evidence-based practices into the continuing professional development of current and future...
Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Type 2 Diabetes A Randomized Clinical Trial
Abstract Importance Evidence of effective smoking cessation interventions in patients with diabetes is limited. The unique behavioral and metabolic characteristics of smokers with type 2 diabetes warrants a randomized clinical trial of the...
New Psychoactive Substances (NPS) Webinar Series
Various NPS have significantly changed the picture of drug use in different countries. They are now very prominent in the drug market. Indeed, many of these substances are intended to circumvent drug laws and are sold as ‘legal’...
Oxytocin as an adolescent treatment for methamphetamine addiction after early life stress in male and female rats
Abstract Early life stress (ELS) is associated with perturbed neural development and augmented vulnerability to mental health disorders, including addiction. How ELS changes the brain to increase addiction risk is poorly understood, and...
Highlights from the 2022 UNODC World Drug Report: Implications for drug prevention, treatment and care responses
ISSUP presented a webinar on Thursday, July 7, 2022, featuring Giovanna Campello, Chief of the Prevention, Treatment and Rehabilitation Section, United Nations Office on Drugs and Crime (UNODC) presenting highlights from the 2022 edition of...
Involvement of the ghrelin system in the maintenance and reinstatement of cocaine-motivated behaviors: a role of adrenergic action at peripheral β1 receptors
Abstract Cocaine addiction is a significant medical and public concern. Despite decades of research effort, development of pharmacotherapy for cocaine use disorder remains largely unsuccessful. This may be partially due to insufficient...
The prevalence of comorbid serious mental illnesses and substance use disorders in prison populations: a systematic review and meta-analysis
Comorbid mental illnesses and substance use disorders are associated with adverse criminal, social, and health outcomes. Yet, their burden is not reliably known among prison populations. We therefore aimed to estimate the prevalence of comorbid serious mental illnesses and substance use disorders (dual disorders) among people in prison worldwide.